<?xml version="1.0" encoding="UTF-8"?><protocol_summary><protocol><id>13828</id><no>EPROMPT-CA</no><status>Open</status><title>CoreValve Evolut PRO Prospective Registry</title><objective>The primary objective of this study is to evaluate the real-world performance of the CoreValve Evolut PRO transcatheter aortic valve, including leaflet function, in a prospective observational registry.&#xD;
</objective><nct_id>NCT01737528</nct_id><sponsor_type>Industrial; Institutional</sponsor_type><age_group>Adult</age_group><treatment_type>Observational</treatment_type><treatment>Device: TAVR&#xD;
</treatment><phase>N/A</phase><scope>Local</scope><disease_site>Diseases Of The Circulatory System</disease_site><lay_description>This study investigates the following conditions or diseases: Aortic Stenosis&#xD;
</lay_description><PI>Waksman, Ron</PI><institution>MedStar Health and GUMC; Medstar Washington Hospital Center</institution><management_group>MCRN - Wash Interventional - ARO</management_group></protocol><sipVersion>2026.1.0 Build 16</sipVersion><copyright> &lt;a href="https://advarra.com" target="_blank"&gt;&amp;copy; 2026 Advarra, Inc.&lt;/a&gt; </copyright></protocol_summary>